Inventor · disambiguated record
Bjarne Due Larsen
Also filed as: LARSEN BJARNE · LARSEN BJARNE D · LARSEN BJARNE DUE
37 granted patents·37 pending applications·975 citations·filing 2000–2024
98Inventor score
Top patents by PatentIndex Score
74 records- 0197US7935786B2Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysisZEALAND PHARMA AS·Filed 2007·Granted May 3, 2011·48 cites·26 claims
- 0295US7414107B2Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysisZEALAND PHARMA AS·Filed 2004·Granted Aug 19, 2008·57 cites·8 claims
- 0395US7348404B2Solid-phase peptide synthesis and agent for use in such synthesisZEALAND PHARMA AS·Filed 2006·Granted Mar 25, 2008·41 cites·5 claims
- 0495US6528486B1Peptide agonists of GLP-1 activityZEALAND PHARMA AS·Filed 2000·Granted Mar 4, 2003·303 cites·2 claims
- 0594US8642727B2Selective glucagon-like-peptide-2 (GLP-2) analoguesLARSEN BJARNE DUE·Filed 2007·Granted Feb 4, 2014·37 cites·6 claims
- 0694US7563770B2Glucagon-like-peptide-2 (GLP-2) analoguesZEALAND PHARMA AS·Filed 2006·Granted Jul 21, 2009·25 cites·2 claims
- 0793US9580487B2Method of treating stomach or bowel-related disorders by administering glucagon-like-peptide-2 (GLP-2) analoguesZEALAND PHARMA AS·Filed 2015·Granted Feb 28, 2017·12 cites·20 claims
- 0893US8685919B2Glucagon analoguesMEIER EDDI·Filed 2008·Granted Apr 1, 2014·27 cites·37 claims
- 0993US7745403B2Methods of treating chemotherapy-induced diarrhea/mucositis using glucagon-like-peptide-2(GLP-2)analoguesZEALAND PHARMA AS·Filed 2006·Granted Jun 29, 2010·18 cites·2 claims
- 1093US7622496B2Modified lysine-mimetic compoundsZEALAND PHARMA AS·Filed 2006·Granted Nov 24, 2009·49 cites·4 claims
- 1192US8642541B2Glucagon analoguesMEIER EDDI·Filed 2008·Granted Feb 4, 2014·27 cites·30 claims
- 1292US8642540B2Glucagon analoguesMEIER EDDI·Filed 2008·Granted Feb 4, 2014·26 cites·27 claims
- 1392US8163696B2Treatment of inflammatory bowel disease using glucagon-like-peptide-2 (GLP-2) analoguesLARSEN BJARNE DUE·Filed 2009·Granted Apr 24, 2012·16 cites·4 claims
- 1492US7250397B2Antiarrhythmic peptidesZEALAND PHARMA AS·Filed 2001·Granted Jul 31, 2007·35 cites·10 claims
- 1591USRE45313EExendin variant peptidesZEALAND PHARMA AS·Filed 2013·Granted Dec 30, 2014·15 cites·4 claims
- 1691US8680049B2Glucagon analoguesMEIER EDDI·Filed 2008·Granted Mar 25, 2014·27 cites·36 claims
- 1791US8263552B2Glucagon-like-peptide-2 (GLP-2) analoguesLARSEN BJARNE DUE·Filed 2009·Granted Sep 11, 2012·13 cites·8 claims
- 1889US10253078B2GIP agonist compounds and methodsZEALAND PHARMA AS·Filed 2015·Granted Apr 9, 2019·5 cites·18 claims
- 1989US9125882B2Glucagon-like-peptide-2 (GLP-2) analoguesLARSEN BJARNE DUE·Filed 2012·Granted Sep 8, 2015·10 cites·11 claims
- 2089US7544657B2Stabilized Exendin-4 compoundsZEALAND PHARMA AS·Filed 2003·Granted Jun 9, 2009·67 cites·32 claims
- 2189US7153822B2Compositions and methods for modulating connexin hemichannelsWYETH CORP·Filed 2003·Granted Dec 26, 2006·50 cites·4 claims
- 2286US7176282B1Solid-phase peptide synthesis and agent for use in such synthesisZEALAND PHARMA AS·Filed 2000·Granted Feb 13, 2007·14 cites·10 claims
- 2383US7585839B2Medical uses of intercellular communication facilitating compoundsZEALAND PHARMA AS·Filed 2003·Granted Sep 8, 2009·25 cites·20 claims
- 2483US2025122260A1Glucagon-like-peptide-2 (glp-2) analoguesZEALAND PHARMA AS·Filed 2024·Application pending·0 cites
- 2580US11001619B2GIP agonist compounds and methodsZEALAND PHARMA AS·Filed 2019·Granted May 11, 2021·1 cites·2 claims
- 2680US8703702B2Therapeutically active α-MSH analoguesABBVIE INC·Filed 2013·Granted Apr 22, 2014·5 cites·12 claims
- 2780US2024209054A1Gip agonist compounds and methodsZEALAND PHARMA AS·Filed 2023·Application pending·0 cites
- 2879US8026272B2Modified lysine-mimetic compoundsZEALAND PHARMA AS·Filed 2009·Granted Sep 27, 2011·3 cites·6 claims
- 2976US8563508B2Method for preventing or reducing acute renal failure by administration of therapeutically active α-MSH analoguesABBVIE INC·Filed 2013·Granted Oct 22, 2013·3 cites·3 claims
- 3076US7550425B2Diuretic peptide conjugatesZEALAND PHARMA AS·Filed 2005·Granted Jun 23, 2009·2 cites·31 claims
- 3175US7244701B2Diuretic peptide conjugateZEALAND PHAMA AS·Filed 2001·Granted Jul 17, 2007·8 cites·19 claims
- 3271US11814417B2GIP agonist compounds and methodsZEALAND PHARMA AS·Filed 2021·Granted Nov 14, 2023·0 cites·21 claims
- 3371US10092648B2Selective glucagon-like-peptide-2 (GLP-2) analoguesZEALAND PHARMA AS·Filed 2014·Granted Oct 9, 2018·1 cites·17 claims
- 3471US8466104B2Therapeutically active alpha MSH analoguesJONASSEN THOMAS E N·Filed 2005·Granted Jun 18, 2013·3 cites·3 claims
- 3569US8431540B2Modified lysine-mimetic compoundsLARSEN BJARNE DUE·Filed 2011·Granted Apr 30, 2013·1 cites·14 claims
- 3667US2021309708A1Glucagon-like-peptide-2 (glp-2) analoguesZEALAND PHARMA AS·Filed 2021·Application pending·0 cites
- 3766US2008227954A1Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysisLARSEN BJARNE D·Filed 2007·Application pending·0 cites
- 3865US7737113B2Antiarrhythmic peptidesZEALAND PHARMA AS·Filed 2004·Granted Jun 15, 2010·1 cites·15 claims
- 3965US2008234467A1Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysisLARSEN BJARNE DUE·Filed 2007·Application pending·0 cites
- 4065US2018362611A1Peptide agonists of glp-1 activityZEALAND PHARMA AS·Filed 2018·Application pending·0 cites
- 4165US2008015152A1Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysisLARSEN BJARNE D·Filed 2007·Application pending·0 cites
- 4265US2008139785A1Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysisLARSEN BJARNE DUE·Filed 2007·Application pending·0 cites
- 4363US2014336356A1Peptide agonists of glp-1 activityZEALAND PHARMA AS·Filed 2013·Application pending·0 cites
- 4462US2019330295A1Glucagon-like-peptide-2 (glp-2) analoguesZEALAND PHARMA AS·Filed 2019·Application pending·0 cites
- 4562US2017137487A1Glucagon-like-peptide-2 (glp-2) analoguesZEALAND PHARMA AS·Filed 2017·Application pending·0 cites
- 4661US2013210722A1Methods for using peptide agonists having glp-1 activityZEALAND PHARMA AS·Filed 2013·Application pending·0 cites
- 4760US2017107267A1Peptide agonists of glp-1 activityZEALAND PHARMA AS·Filed 2016·Application pending·0 cites
- 4858US2025154198A1Peptide inhibitors of interleukin-23 receptorZEALAND PHARMA AS·Filed 2022·Application pending·0 cites
- 4958US2011312878A1Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysisLARSEN BJARNE DUE·Filed 2011·Application pending·0 cites
- 5056US2013225644A1Modified lysine-mimetic compoundsZEALAND PHARMA AS·Filed 2013·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bjarne Due Larsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →